Advertisements



Gemphire Therapeutics stock tumbles 17% premarket after trial halt

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchAug 10th, 2018

Gemphire Therapeutics" stock extends slide, plummets 39% premarket after trial halt

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchAug 10th, 2018

Gemphire"s stock more than doubles on heavy volume after upbeat trial results

Shares of Gemphire Therapeutics Inc. more than doubled (up 142%) in active premarket trade Friday, after the biopharmaceutical company said a phase 2b trial for gemcabene, a treatment for severe hypertriglycer.....»»

Category: topSource: marketwatchJun 29th, 2018

Adaptimmune"s stock tumbles after cancer study results prompts price target cut

Shares of Adaptimmune Therapeutics PLC slumped 21% in morning trade Monday, after the results from a trial of its cancer treatment prompted Raymond James to slash its price target. The biopharmaceutical company.....»»

Category: topSource: marketwatchOct 22nd, 2018

Mirati Therapeutics stock drops 30% premarket after cancer trial results

Mirati Therapeutics Inc. shares dropped 30% in Monday premarket trade after the company presented results from a phase 2 trial in which its cancer drug sitravatinib was combined with Bristol-Myers Squibb Co.'s cancer drug Opdivo . The trial enrolled p.....»»

Category: topSource: marketwatchOct 22nd, 2018

Proteostasis Therapeutics" stock more than triples after positive trial results

Shares of Proteostasis Therapeutics Inc. more than tripled (up 207%) in premarket trade on heavy volume, after the biopharmaceutical company announced positive results from .....»»

Category: topSource: marketwatchOct 18th, 2018

Viking Therapeutics stock jumps 4.8% premarket on news of positive trial results

Viking Therapeutics Inc. shares surged x% in premarket trade Monday, after the company reported positive results in a mid-stage trial of a treatment for broken hips. The company said its Phase 2 trial of VK5.....»»

Category: topSource: marketwatchOct 1st, 2018

Alderya"s stock rockets after positive trial results of mesothelioma treatment

Shares of Aldeyra Therapeutics Inc. rocketed 35% toward a record high in active premarket trade Wednesday, after the biotechnology company announced positive results from a phase 1/2 trial of its treatment for pleural m.....»»

Category: topSource: marketwatchSep 26th, 2018

Galectin stock lifts 15% premarket on early cancer combination trial results

Galectin Therapeutics Inc. shares surged 15% in Thursday premarket trade after the company said that combining its therapy, GR-MD-02, with Key.....»»

Category: topSource: marketwatchSep 20th, 2018

UPDATE: Viking Therapeutics stock rockets 140% after positive trial of non-alcoholic fatty liver treatment

Viking Therapeutics Inc. stock rocketed 140% in premarket trade Tuesday, after the company reported positive results in a mid-stage tr.....»»

Category: topSource: marketwatchSep 18th, 2018

Viking Therapeutics stock rockets 140% premarket as trading resumes after halt

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchSep 18th, 2018

Sangamo stock drops 13% premarket on results of phase 1/2 gene editing trial

Sangamo Therapeutics Inc. shares dropped 13% in Wednesday premarket trade after the company released results for a phase 1/2 trial of its gene editing candidate SB-913, which is intended for the .....»»

Category: topSource: marketwatchSep 5th, 2018

Gemphire Therapeutics stock plunges after trial halted due to "unanticipated problems"

Shares of Gemphire Therapeutics Inc. plunged 17% toward a record low F.....»»

Category: topSource: marketwatchAug 10th, 2018

Spark Therapeutics stock plummets 28% premarket on hemophilia trial"s patient safety concerns

Spark Ther.....»»

Category: topSource: marketwatchAug 7th, 2018

Spark Therapeutics stock plummets 25% premarket on hemophilia trial"s patient safety concerns

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchAug 7th, 2018

UPDATE: Cara Therapeutics stock surges 34% on news of positive results in trial of post-surgery pain treatment

Cara Therapeutics Inc. shares soared 34% in premarket trade Wednesday, after the company reported positive data in a Phase 2/3 trial of a t.....»»

Category: topSource: marketwatchJun 27th, 2018

Menlo Therapeutics" stock plunges over 50% after disappointing trial results

Shares of Menlo Therapeutics Inc. lost more than half their value in premarket trade Monday, after the biopharmaceutical company's skin condition treatment failed to meet its primary or key secondary efficacy endpoints. The phase 2 trial showed no stat.....»»

Category: topSource: marketwatchApr 9th, 2018

UPDATE: Axsome Therapeutics shares soar 24% premarket on positive trial of Alzheimer"s therapy

Shares of Axsome Therapeutics Inc. surged about 24% premarket Monday, after the biotech, which special.....»»

Category: topSource: marketwatchDec 10th, 2018

Axsome Therapeutics shares soar 12% premarket on positive trial of Alzheimer"s therapy

Shares of Axsome Therapeutics Inc. surged about 12% premarket Monday, after the biotech, which special.....»»

Category: topSource: marketwatchDec 10th, 2018

Aphria"s stock tumbles 15% premarket, after plunging 23% on Monday after a negative short-seller report

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchDec 4th, 2018

Vivint Solar"s stock tumbles after share offering prices at deep discount

Shares of Vivint Solar Inc. tumbled 16% in premarket trade Friday, after residential solar company said the share offering by its principal stockholder priced at a deep discount. The company said late Thursday.....»»

Category: topSource: marketwatchNov 30th, 2018